Vontobel Holding
GSK icon

Vontobel Holding’s GSK GSK Stock Holding History

Vontobel Holding’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$447K Sell
8,537
-348
-4% -$18.4K ﹤0.01% 1090
2026
Q1 		$490K Sell
8,885
-1,602
-15% -$86.8K ﹤0.01% 859
2025
Q4 		$514K Sell
10,487
-550
-5% -$25.7K ﹤0.01% 984
2025
Q3 		$476K Sell
11,037
-605
-5% -$23.6K ﹤0.01% 962
2025
Q2 		$447K Sell
11,642
-470
-4% -$18K ﹤0.01% 932
2025
Q1 		$469K Buy
12,112
+1,437
+13% +$52.6K ﹤0.01% 802
2024
Q4 		$361K Buy
10,675
+280
+3% +$10.1K ﹤0.01% 874
2024
Q3 		$425K Sell
10,395
-953
-8% -$39K ﹤0.01% 831
2024
Q2 		$437K Sell
11,348
-499
-4% -$21K ﹤0.01% 809
2024
Q1 		$508K Sell
11,847
-1,228
-9% -$50.6K ﹤0.01% 767
2023
Q4 		$485K Sell
13,075
-878
-6% -$31.5K ﹤0.01% 804
2023
Q3 		$506K Sell
13,953
-2,554
-15% -$90.7K ﹤0.01% 766
2023
Q2 		$588K Buy
+16,507
New +$592K 0.01% 750
2022
Q3 		– Sell
-18,350
Closed -$998K – 1060
2022
Q2 		$998K Sell
18,350
-3,168
-15% -$175K 0.01% 540
2022
Q1 		$1.17M Sell
21,518
-9,686
-31% -$526K 0.01% 571
2021
Q4 		$1.72M Buy
31,204
+98
+0.3% +$5.1K 0.01% 481
2021
Q3 		$1.49M Buy
31,106
+4,163
+15% +$209K 0.01% 515
2021
Q2 		$1.34M Sell
26,943
-778,172
-97% -$37.4M 0.01% 524
2021
Q1 		$35.9M Sell
805,115
-6,697
-0.8% -$304K 0.27% 50
2020
Q4 		$37.3M Buy
+811,812
New +$37.3M 0.24% 58

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Vontobel Holding's GSK Position: Q2 2026 in Review

Vontobel Holding reduced its GSK (GSK) stake by 3.9% in Q2 2026, selling an estimated $18.4K and leaving 8,537 shares worth $447K. The position accounts for ﹤0.01% of the portfolio, ranked #1090.

Vontobel Holding first reported a position in GSK in Q4 2020 and has held it in 20 quarters since. The position peaked at $37.3M in Q4 2020. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Vontobel Holding held 8,537 shares of GSK worth $447K as of Q2 2026.
  • Vontobel Holding sold 348 GSK shares in Q2 2026, an estimated $18.4K.
  • GSK made up ﹤0.01% of Vontobel Holding's portfolio in Q2 2026, its #1090 holding.
  • Vontobel Holding first reported a position in GSK in Q4 2020 and has held it in 20 quarters since.
  • Vontobel Holding's GSK position peaked at $37.3M in Q4 2020.
  • 1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Vontobel Holding's 13F filing for Q2 2026, filed 3 Aug 2026.